Quintrio
Home

SERVICES-HOME HEALTH CARE SERVICES

Addus HomeCare Corp.

ADUS

Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.

Last trade $123.49
Day change -$1.12 (-0.90%)
Day range $122.45 – $124.87
Volume 51,625
Market cap $2.32B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$2.32B
Price / earnings
20.91×
Price / book
1.97×
Price / sales
1.55×
EV / sales
1.5×
EV / EBITDA
13.09×

Profitability

Earnings per share
$5.96
Return on assets
7.66%
Return on equity
9.41%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.02×
Current ratio
1.64×
Quick ratio
1.64×
Cash ratio
0.57×

Cash flow

Price / cash flow
15.27×
Price / free cash flow
16.1×
Free cash flow
$144.23M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ADUS, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$387.73M$377.42M$363.61M$373.08M$362.3M$349.44M$337.71M$297.14M
Cost of revenue$263.34M$255.86M$247.74M$249.47M$245.59M$235.57M$230.03M$195.66M
Gross profit$124.4M$121.56M$115.87M$123.61M$116.72M$113.88M$107.68M$101.48M
Selling, general and administrative$80.44M$78.49M$77.77M$77.18M$79.37M$77.08M$73.22M$71.36M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$84.58M$82.62M$81.8M$81.33M$83.78M$80.99M$77.16M$74.57M
Operating income$39.82M$38.94M$34.07M$42.28M$32.94M$32.89M$30.51M$26.91M
Interest expense-$1.26M-$1.72M-$2.15M-$2.73M-$3.34M-$3.53M-$4.02M-$2.29M
Income before taxes$39.14M$37.78M$32.43M$40.15M$30.35M$29.95M$27M$26.21M
Income taxes$10.55M$10.18M$7.36M$10.37M$7.51M$7.89M$5.77M$6.69M
Net income$28.59M$27.61M$25.07M$29.78M$22.85M$22.05M$21.23M$19.53M
Net income attributable to common shareholders$28.59M$27.61M$25.07M$29.78M$22.85M$22.05M$21.23M$19.53M
EBITDA$43.96M$43.07M$38.1M$46.43M$37.35M$36.8M$34.46M$30.13M
Basic earnings per share$1.56$1.51$1.38$1.64$1.26$1.22$1.18$1.09
Diluted earnings per share$1.54$1.49$1.36$1.61$1.24$1.20$1.16$1.06

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

What Makes Addus HomeCare (ADUS) a Strong Momentum Stock: Buy Now?

Addus HomeCare (ADUS) demonstrates positive momentum with a Zacks Momentum Style Score of B and a #2 (Buy) rating. The stock has outperformed its industry over multiple timeframes, with shares up 3.06% weekly and 10.98% monthly, while earnings estimates have been revised upward over the past two months.

Zacks Investment Research

Addus HomeCare (ADUS) Reports Q3 Earnings: What Key Metrics Have to Say

Addus HomeCare reported Q3 2026 revenue of $387.73 million, up 7% year-over-year, slightly missing the consensus estimate of $388.36 million. EPS came in at $1.83, beating the consensus estimate of $1.78 by 2.81%. Personal care revenue grew 9.2% while home health and hospice segments showed minimal growth. The stock has a Zacks Rank #3 (Hold) rating.

Zacks Investment Research

Addus HomeCare (ADUS) Surpasses Q3 Earnings Estimates

Addus HomeCare reported Q3 2026 earnings of $1.83 per share, beating consensus estimates of $1.78, but revenues of $387.73 million slightly missed expectations. The company has outperformed the market by 17.1% year-to-date. With a Zacks Rank #3 (Hold) rating and mixed estimate revisions, the stock is expected to perform in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 39% of Zacks industries.

Zacks Investment Research

Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates

Quest Diagnostics reported Q3 2026 earnings of $3.00 per share, beating consensus estimates of $2.85 and surpassing revenue expectations at $3.1 billion. The company has beaten EPS estimates in four consecutive quarters. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions, suggesting near-term performance in line with the market. The Medical - Outpatient and Home Healthcare industry ranks in the top 31% of Zacks industries.

Zacks Investment Research

BTSG Deploys AI Across Operations: Will It Improve Margins?

BrightSpring Health Services is leveraging AI and automation across hiring, intake, documentation, and patient care to improve productivity. The company reported 44% year-over-year adjusted EBITDA growth with margin expansion to 5.3%, with further benefits expected in late 2026 and early 2027. Peers Option Care Health and Addus HomeCare are similarly implementing AI-driven initiatives to enhance efficiency and reduce operational complexity.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.